In this setting, the potential utility of CXCL10 measurement in clinical practice is likely to diminish in light of recent evidence that early treatment of HIV infection is beneficial irrespective of baseline CD4+ T cell count or plasma viral load [1]. Here, CD4 is linked to HIV infectious disease.